Fractyl Health (GUTS) Interest & Investment Income (2023 - 2026)
Fractyl Health (GUTS) reported Interest & Investment Income of $593000.0 for Q1 2026, up 17.89% year-on-year from $503000.0 in Q1 2025, and down 8.06% quarter-over-quarter from $645000.0 in Q4 2025.
Fractyl Health (GUTS) has 4 years of Interest & Investment Income data on file, last reported at $593000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 17.89% year-over-year to $593000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 54.1% YoY), and the FY2025 full-year result was $1.5 million, down 62.86% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $593000.0, down from $645000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.4 million in Q2 2024 and bottomed at $154000.0 in Q2 2023.
- A 4-year average of $579923.1 and a median of $503000.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 792.86% in 2024 and sank 83.56% in 2025, its largest moves.
- Tracing GUTS's Interest & Investment Income over 4 years: stood at $463000.0 in 2023, then jumped by 56.8% to $726000.0 in 2024, then declined by 11.16% to $645000.0 in 2025, then slipped by 8.06% to $593000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $593000.0, $645000.0, and $166000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 593,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 593,000.00 |
| Dec 31, 2025 | 645,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 226,000.00 |
| Mar 31, 2025 | 503,000.00 |
| Dec 31, 2024 | 726,000.00 |
| Sep 30, 2024 | 947,000.00 |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 463,000.00 |
| Sep 30, 2023 | 226,000.00 |
| Jun 30, 2023 | 154,000.00 |
| Mar 31, 2023 | 417,000.00 |